PET scan with a new tracer for lung cancer brain metastases
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This Phase 1 study tests whether a specialized PET scan tracer can “light up” metastatic non-small cell lung cancer in the brain. If you join, you’ll get brain MRI and PET/CT scans and you’ll continue with your planned cancer treatments and follow-up imaging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have biopsy-confirmed non-small cell lung cancer that has spread to the brain
- Have an expected survival of at least 3 months (as judged by your treating doctor)
- Have tumor tissue available from a biopsy or surgery (archival tissue is acceptable)
- Be able to complete scans—stay still for about 30–60 minutes per scan, and meet scan weight limits (up to 350 lbs)
- Be able to do MRI and PET/CT soon after enrollment (both within 21 days) and have adequate kidney function for the study testing (GFR 60 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial studies how well a special PET scan tracer (18F-fluciclovine) shows amino-acid changes in brain metastases after they are surgically removed. It may help improve how doctors detect and understand brain metastases and guide follow-up treatment like targeted radiation (SRS).
This trial tests a special PET scan (18F-fluciclovine) to see how well it shows brain metastases after stereotactic radiosurgery (a precise form of radiation). It may help doctors better understand treatment effects.
This trial tests a new PET scan tracer to see inflammation in brain tumors that have not been treated with radiation. It may help doctors better understand and monitor these tumors.
This Phase 1 study tests an injected radioactive tracer (18F-fluciclovine) to improve how doctors image and assess large brain metastases. It may help guide treatment when you’re receiving staged stereotactic radiosurgery (focused radiation in steps).
This study uses a special type of brain scan (PET imaging) to better understand how cancer that has spread to the brain responds to radiation treatment. The scan may help doctors see which patients are responding well to treatment.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.